ArcticZymes Technologies ASA (OSL:AZT)

Market Cap	868.21M
Revenue (ttm)	108.11M
Net Income (ttm)	7.57M
Shares Out	51.07M
EPS (ttm)	0.15
PE Ratio	113.33
Forward PE	85.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,257
Average Volume	32,905
Open	16.00
Previous Close	16.90
Day's Range	16.15 - 17.00
52-Week Range	12.34 - 27.75
Beta	1.36
RSI	51.53
Earnings Date	May 8, 2025

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during man...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 61
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 7.57 million, a decrease of -61.02%.